Navigation Links
SAFC(R) & Cherokee Pharmaceuticals(TM) Pool Expertise and Resources With Strategic Partnership For U.S. Market

Collaboration Delivers Cost and Quality Benefits for Widespread cGMP Distribution

ST. LOUIS and PHILADELPHIA, June 1 /PRNewswire-FirstCall/ -- SAFC(R) (, a member of the Sigma-Aldrich(R) group (Nasdaq: SIAL) and Cherokee Pharmaceuticals(TM) (, a PRWT Services, Inc. company and minority owned business, today announced an exclusive strategic partnership that encompasses the sourcing, analytical testing, warehousing, packaging and distribution of large-scale raw materials for pharmaceutical manufacturing meeting cGMP quality standards.

The collaboration to co-market and co-sell raw materials for pharmaceutical customers will draw upon SAFC's global sourcing and production capabilities and combine these with Cherokee's world-class analytical laboratories, large-scale cGMP manufacturing, warehousing and distribution facilities. Under the agreement, SAFC will be responsible for all product sourcing including processing reagents and excipients from its network of over 10,000 active suppliers while Cherokee Pharmaceuticals will conduct analytical testing, storage, packaging and distribution services.

Located in Riverside, PA, Cherokee Pharmaceuticals features significant storage and expansion capabilities and has its own dedicated rail link to potentially serve the Northeast United States corridor where many of the world's leading pharmaceutical companies are located. SAFC will utilize Cherokee's fully cGMP validated site, which can house cooled, frozen and hazardous substances and serve as a key East Coast analytical, warehousing and distribution hub for large-scale raw materials towards the pharmaceutical industry.

Commenting on the strategic partnership Gilles Cottier, President of SAFC said: "This agreement is a win-win situation, not only for SAFC and Cherokee Pharmaceuticals, but also for our respective customers. In marrying SAFC's sourcing capabilities, which bring significant cost and quality benefits to the table, with Cherokee Pharmaceuticals expertise in analytical testing and cGMP manufacture and storage, we are providing top level, high-quality resourcing that will support our US customers throughout their respective supply chains, enabling them to both streamline and improve their risk mitigation strategies."

Murvin Lackey, President of Distribution for Cherokee Pharmaceuticals added, "The core competencies of both companies present a competitive advantage for us and our customers. This strategic partnership allows us to provide an integrated sourcing, distribution process to our customers who seek a secure supply chain."

About SAFC: SAFC(R) is the custom manufacturing and services group within Sigma-Aldrich that focuses on high-purity inorganics for high technology applications, cell culture products and services for biopharmaceutical manufacturing, biochemical production and the manufacturing of complex, multi-step organic synthesis of APIs and key intermediates. SAFC has manufacturing facilities around the world dedicated to providing manufacturing services for companies requiring a reliable partner to produce their custom manufactured materials. SAFC has four business segments - SAFC Pharma(R), SAFC Supply Solutions(R), SAFC Biosciences(R), and SAFC Hitech(R)- and had annual sales of over $600 million in 2008. SAFC is considered a top 10 fine chemical company. For more information about SAFC, visit

About Sigma-Aldrich: Sigma-Aldrich is a leading Life Science and High Technology company. Its biochemical and organic chemical products and kits are used in scientific research, including genomic and proteomic research, biotechnology, pharmaceutical development and as key components in pharmaceutical, diagnostic and other high technology manufacturing. The Company has customers in life science companies, university and government institutions, hospitals, and in industry. Over one million scientists and technologists use its products. Sigma-Aldrich operates in 37 countries and has 7,900 employees providing excellent service worldwide. Sigma-Aldrich is committed to Accelerating Customer Success through Innovation and Leadership in Life Science, High Technology and Service. For more information about Sigma-Aldrich, please visit its award-winning Web site at

About Cherokee Pharmaceuticals: Cherokee Pharmaceuticals, a PRWT Services, Inc. company, is a bulk chemical manufacturing and distribution company producing active pharmaceutical ingredients (APIs). Cherokee is the country's only minority-owned outsourced API provider. With a highly skilled workforce, cGMP facilities, and a 59-year history in fine chemical manufacturing, Cherokee Pharmaceuticals offers high-quality U.S. based manufacturing at a competitive cost. It has specialized skills in handling antibiotics, high hazard reactions and potent compounds. Cherokee Pharmaceuticals' APIs are used in several antibiotics for human and animal health, as well as in new compounds for cholesterol management and HIV treatment

SAFC(R), SAFC Supply Solutions(R) and Sigma-Aldrich(R) are registered trademarks of Sigma-Aldrich Biotechnology L.P. and Sigma-Aldrich Co.

Cherokee Pharmaceuticals (TM) is a trademark of PRWT Services Inc.

SOURCE Sigma-Aldrich Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. SAFC(R) Underlines Commitment to Pharmaceutical Supply Chain Quality With New Global Vendor Audit Services
2. National Cherokee Inspired Comfort Award Winners Announced
3. Cherokee Health Tee Proceeds Benefit Breast Cancer Research
4. Cherokee Inspired Comfort Awards Program Call for Nominations
5. Cherokee Inspired Comfort Awards Program Call for Nominations
6. AWWA, National Association of Water and Sanitation of Mexico, Agree to Share Expertise and Resources for Improved Water Supply
7. Euro RSCG Life Broadens X2 Expertise
8. Three Batesville Casket Company Production Facilities Honored for Manufacturing Expertise by National Organizations
9. Franklin & Seidelmann Adds 31 Subspecialty Radiologists to Support Growing Demand for Subspecialty Expertise
10. Caris Diagnostics Announces Addition of Leading Dermatopathologist to Expand Subspecialty Expertise
11. Customer Communications Group Selected by The Childrens Hospital for Direct Marketing Expertise
Post Your Comments:
(Date:11/27/2015)... ... 27, 2015 , ... The rapid speed at which Americans ... more care is needed, especially with Alzheimer’s, dementia and other cognitive conditions becoming ... The forgotten part of this equation: 80 percent of medical care occurs in ...
(Date:11/27/2015)... NC (PRWEB) , ... November 27, 2015 , ... A ... effective ways to treat it. Surviving Mesothelioma has just posted the findings on ... at University Hospital Zurich analyzed the cases of 136 mesothelioma patients who were treated ...
(Date:11/27/2015)... ... November 27, 2015 , ... An inventor, from Hopkinsville, ... prescription medications at home, so he invented the patent-pending ELECTRONIC M.D. , The ... medications. In doing so, it could help to prevent potential overdose situations. As ...
(Date:11/27/2015)... PITTSBURGH, PA (PRWEB) , ... November 27, 2015 ... ... of how filthy the toilets were," said an inventor from Hillside, N.J. "Many ... this improved seat cover so that individuals will always be protected from germs." ...
(Date:11/27/2015)... ... 27, 2015 , ... Lizzie’s Lice Pickers just announced a special promotion that ... of their purchase of lice treatment product. In addition, customers will receive a complimentary ... spokesperson. “Finding lice is a sure way to ruin the holidays, so we encourage ...
Breaking Medicine News(10 mins):
(Date:11/27/2015)... , November 27, 2015 ... is set to go online. The potential to save ... is vast and far from fully exploited as yet. ... patient health records, either via mobile tablet or directly ... --> ) --> ...
(Date:11/27/2015)... , Niederlande, November 27, 2015 ... fotodynamischer Bremachlorin-Therapie bei fortgeschrittenem Krebs.   --> ... Bremachlorin-Therapie bei fortgeschrittenem Krebs.   --> ... Bremachlorin-Therapie bei fortgeschrittenem Krebs.   Clinical ... --> Clinical Cancer Research vom ...
(Date:11/27/2015)... , Nov. 27, 2015  Lannett Company, ... it has completed the acquisition of Kremers Urban ... subsidiary of global biopharmaceuticals company UCB S.A. (Euronext: ... Lannett has acquired KU from UCB for ... certain adjustments, including a customary working capital adjustment, ...
Breaking Medicine Technology: